Soligenix, Inc. ( SNGX) - Stock Earnings
SNGX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -2.5 million USD | — USD |
| 2025Q4 | -2.9 million USD | — USD |
| 2026Q1 | -2.8 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
SNGX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -6.1 million USD | 839359 USD |
| 2024 | -8.3 million USD | 119371 USD |
| 2025 | -11.1 million USD | — USD |
| 2026 Est. | — | — |
SNGX
Price: $0.40
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.14 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 16498
Ebitda: -951647Market Capitalization: 4.6 million